Abstract
The more powerful psychoactive substances have been controlled due to the harms they cause to public health. Those that were found in certain regions of the world have been controlled by international treaties, limiting their use to medical and scientific purposes. The treaties also established a system to carefully assess the benefits and harms of new substances and control them accordingly; control is then enforced by criminal penalties at national level. This established system is now under pressure due to globalisation and the internet, with two new substances found in Europe every week, and countries look for new ways to control substances quickly without the need to prove a public health threat. In some countries, “psychoactive” moves towards becoming a synonym for “harmful”; in others, supply of low-risk substances for non-medical use is now permitted.
Similar content being viewed by others
References
Anderson, P., & Baumberg, B. (2006). Alcohol in Europe – A public health perspective. London: Institute of Alcohol Studies.
Ballotta, D., Bergeron, H., & Hughes, B. (2008). Cannabis control in Europe. In EMCDDA (Ed.), A cannabis reader: Global issues and local experiences (Monograph series 8, Vol. 1, pp. 97–116). Lisbon: EMCDDA.
Danenberg, E., Sorge, L., Wieniawski, W., Elliott, S., Amato, L., & Scholten, W. (2013). Modernizing methodology for the WHO assessment of substances for the international drug control conventions. Drug and Alcohol Dependence, 131, 175–181.
EMCDDA. (2009). Risk assessment of new psychoactive substances operating guidelines. Lisbon: EMCDDA.
EMCDDA. (2015). Perspectives on drugs; Legal approaches to controlling new psychoactive substances. Retrieved 2015, from EMCDDA: http://www.emcdda.europa.eu/topics/pods/controlling-new-psychoactive-substances
European Commission. (2009). On the implementation of Framework Decision 2004/757/JHA laying down minimum provisions on the constituent elements of criminal acts and penalties in the field of illicit drug trafficking [SEC(2009)1661].
European Commission. (2013). Proposal for a regulation of the European parliament and of the council on new psychoactive substances COM(2013) 619. European Commission.
European Court of Justice. (2014). Joined cases C-358/13 and C 181/14: Judgment of the court (Fourth chamber) of 10 July 2014. European Union.
Evans-Brown, M., Gallegos, A., Francis, W., Christie, R., Cunningham, A., Sekula, J., et al. (2015). New psychoactive substances in Europe; An update from the EU Early Warning System. Lisbon: EMCDDA.
Hughes, B. (2015). Alternatives to punishment for drug using offenders. Lisbon: EMCDDA.
Hughes, B., & Blidaru, T. (2009). Legal responses to new psychoactive substances in Europe. Lisbon: EMCDDA.
Hughes, B., & Evans-Brown, M. (2015). New psychoactive substances in Europe: Innovative legal responses. Lisbon: EMCDDA.
Hughes, B., & Griffiths, P. (2014). Regulatory approaches to new psychoactive substances (NPS) in the European Union. Addiction, 109, 1591–1593.
Hughes, B., & Winstock, A. (2012). Controlling new drugs under marketing regulations. Addiction, 107, 1894–1899.
Thomson Reuters Aranzadi. (2013). Study on criminal sanction legislation and practice in representative Member States – Final Report. European Commission.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer-Verlag GmbH Deutschland
About this entry
Cite this entry
Hughes, B., Evans-Brown, M., Sedefov, R. (2016). Legal Controls of Psychoactive Substances in Europe. In: von Heyden, M., Jungaberle, H., Majić, T. (eds) Handbuch Psychoaktive Substanzen. Springer Reference Psychologie . Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-55214-4_15-1
Download citation
DOI: https://doi.org/10.1007/978-3-642-55214-4_15-1
Received:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Online ISBN: 978-3-642-55214-4
eBook Packages: Springer Referenz Psychologie